Cubist Systematic Strategies, LLC Aerie Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $33,843 - $80,916	5,313 Added 19.66%	32,335 $489,000
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $408,810 - $756,506	-82,588 Reduced 75.35%	27,022 $203,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $1.95 Million - $3.39 Million	-346,417 Reduced 75.96%	109,610 $997,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $3.2 Million - $6.08 Million	456,027 New	456,027 $3.2 Million
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $1.1 Million - $1.37 Million	-72,413 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $269,025 - $428,554	-20,505 Reduced 22.07%	72,413 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $300,750 - $477,836	-32,977 Reduced 26.19%	92,918 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $186,522 - $257,850	-17,832 Reduced 12.41%	125,895 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $533,040 - $716,494	44,420 Added 44.73%	143,727 $2.12 Million
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $333,686 - $719,230	-28,183 Reduced 22.11%	99,307 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $1.41 Million - $1.99 Million	79,464 Added 165.46%	127,490 $3.08 Million
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $13,034 - $19,824	-708 Reduced 1.45%	48,026 $923,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $1.41 Million - $2.35 Million	48,734 New	48,734 $1.44 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $600,805 - $814,693	-16,542 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $201,630 - $366,844	-6,110 Reduced 26.97%	16,542 $597,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $1.27 Million - $1.67 Million	22,652 New	22,652 $1.39 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $412,190 - $527,700	-8,106 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $393,951 - $487,170	8,106	8,106 $394,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account